These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12770782

  • 1. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
    Sadeghlar F, Remmel N, Breiden B, Klingenstein R, Schwarzmann G, Sandhoff K.
    Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
    [Abstract] [Full Text] [Related]

  • 2. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
    Wilkening G, Linke T, Uhlhorn-Dierks G, Sandhoff K.
    J Biol Chem; 2000 Nov 17; 275(46):35814-9. PubMed ID: 10942779
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
    Schmid B, Paton BC, Sandhoff K, Harzer K.
    Hum Genet; 1992 Jul 17; 89(5):513-8. PubMed ID: 1634229
    [Abstract] [Full Text] [Related]

  • 4. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK, Hüttler S, Klein A, Möbius W, Habermann A, Griffiths G, Sandhoff K.
    Eur J Cell Biol; 1997 May 17; 73(1):10-8. PubMed ID: 9174667
    [Abstract] [Full Text] [Related]

  • 5. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system.
    Henseler M, Klein A, Glombitza GJ, Suziki K, Sandhoff K.
    J Biol Chem; 1996 Apr 05; 271(14):8416-23. PubMed ID: 8626540
    [Abstract] [Full Text] [Related]

  • 6. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.
    Wynn CH.
    Biochem J; 1986 Dec 15; 240(3):921-4. PubMed ID: 3827882
    [Abstract] [Full Text] [Related]

  • 7. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K, Kolter T.
    Acta Biochim Pol; 1998 Dec 15; 45(2):373-84. PubMed ID: 9821868
    [Abstract] [Full Text] [Related]

  • 8. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
    Klein A, Henseler M, Klein C, Suzuki K, Harzer K, Sandhoff K.
    Biochem Biophys Res Commun; 1994 May 16; 200(3):1440-8. PubMed ID: 8185598
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
    Zschoche A, Fürst W, Schwarzmann G, Sanhoff K.
    Eur J Biochem; 1994 May 15; 222(1):83-90. PubMed ID: 8200356
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
    Li SC, Kihara H, Serizawa S, Li YT, Fluharty AL, Mayes JS, Shapiro LJ.
    J Biol Chem; 1985 Feb 10; 260(3):1867-71. PubMed ID: 2981875
    [Abstract] [Full Text] [Related]

  • 13. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
    Paton BC, Schmid B, Kustermann-Kuhn B, Poulos A, Harzer K.
    Biochem J; 1992 Jul 15; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
    [Abstract] [Full Text] [Related]

  • 14. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
    Wrobe D, Henseler M, Huettler S, Pascual Pascual SI, Chabas A, Sandhoff K.
    J Inherit Metab Dis; 2000 Feb 15; 23(1):63-76. PubMed ID: 10682309
    [Abstract] [Full Text] [Related]

  • 15. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
    Fujibayashi S, Wenger DA.
    Biochim Biophys Acta; 1986 Feb 28; 875(3):554-62. PubMed ID: 3081038
    [Abstract] [Full Text] [Related]

  • 16. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
    Sandhoff K, Kolter T, Van Echten-Deckert G.
    Ann N Y Acad Sci; 1998 Jun 19; 845():139-51. PubMed ID: 9668348
    [Abstract] [Full Text] [Related]

  • 17. Glycosphingolipid specificity of the human sulfatide activator protein.
    Vogel A, Schwarzmann G, Sandhoff K.
    Eur J Biochem; 1991 Sep 01; 200(2):591-7. PubMed ID: 1889421
    [Abstract] [Full Text] [Related]

  • 18. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
    Inui K, Wenger DA.
    Arch Biochem Biophys; 1984 Sep 01; 233(2):556-64. PubMed ID: 6435528
    [Abstract] [Full Text] [Related]

  • 19. Sphingolipid hydrolases and activator proteins.
    Bierfreund U, Kolter T, Sandhoff K.
    Methods Enzymol; 2000 Sep 01; 311():255-76. PubMed ID: 10563332
    [No Abstract] [Full Text] [Related]

  • 20. Identity of the activator proteins for the enzymatic hydrolysis of sulfatide, ganglioside GM1, and globotriaosylceramide.
    Vogel A, Fürst W, Abo-Hashish MA, Lee-Vaupel M, Conzelmann E, Sandhoff K.
    Arch Biochem Biophys; 1987 Dec 01; 259(2):627-38. PubMed ID: 3426245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.